Early-stage drug development worldwide has nearly doubled over the past decade and shifted from a U.S.-dominated model to a ...

Information from CMS’s published explanations of the Medicare Drug Price Negotiation Program negotiated prices for 2027 will ...

Adverse drug reactions (ADRs) represent a significant challenge to public health, affecting millions of patients worldwide.

Objective Drug-related problems (DRPs), which encompass medication errors (MEs), adverse drug reactions and adverse drug ...

Strengthening collaboration to drive innovation across AI, biomedical research, and translational medicine PUNE, ...

The introduction of the first disease-modifying therapies fundamentally transformed the management of geographic atrophy and ...

The Calibr-Skaggs Institute for Innovative Medicines at Scripps Research and Kainomyx, Inc., today announced a new research collaboration to accelerate the discovery and development of next-generation ...

GSK Plc’s new chief executive officer plans to speed up research and development and look for acquisitions as the British drugmaker tries to convince investors it can offset a looming patent cliff.

Chairman/Chief Executive Officer of the National Drug Law Enforcement Agency (NDLEA), Brig Gen Mohamed Buba Marwa (rtd), has called for a strong national response and sustained support for the ...

Ulcerative colitis is a chronic inflammatory bowel disease with rising global prevalence. Despite therapeutic advances including biologic agents targeting tumor necrosis factor-alpha, integrins, and ...

United States Drug Testing Laboratories (USDTL), a national leader in forensic and clinical toxicology and mid- to long-term drug and alcohol testing, today announced a new integration partnership ...